My watch list
my.bionity.com  
Login  

Optimizing costs for companies with on-site power generation

Frankfurt-based startup node.energy GmbH secures financing

15-Dec-2017

High-Tech Gründerfonds (HTGF) and 5 Business Angels are investing together just under 1 million euros in node.energy GmbH. The company develops software to optimize energy costs for companies with on-site power generation. The funding will be used to further develop the software and to finance the market launch in Germany.

Over a million small power plants went online in Germany in the last 10 years. At first, the electricity from these plants was simply fed into the public grid and paid for with a subsidized tariff. In the meantime, however, it became profitable to establish so-called microgrids and use the energy directly on site. In this way, energy costs can be saved and the strained electricity networks can be relieved.

However, the implementation of the optimal microgrid concept is complicated and time-consuming up to now. “In Germany alone, industrial consumers with existing small power plants are losing savings of well over EUR 100 million per year – and this number is rising quickly” emphasizes Matthias Karger, co-founder and managing director of node.energy. He adds “even energy consultants and service providers currently have to calculate project per project manually”.

With node.energy’s software application opti.node, all steps for the commercial planning and management of microgrids are automated for the first time. The offer aims at energy managers of commercial real estate with on-site electricity generation. Co-founder and CTO Lars Manuel Rinn explains: “In addition to industrial companies, hospitals, business parks and large hotels benefit from the use of opti.node. The software automatically determines the most cost-effective utilisation for the locally generated electricity and provides all the necessary tools for the implementation and continuous management of the microgrid.”

In the current seed-round the young company from Frankfurt received a total of 775,000 euros in growth capital. The capital will to be used to grow the team, for further development of the software platform and to boost market entry in Germany. Dr. Ulrich Schmitt, Investment Manager at High-Tech Gründerfonds explains: “In a decentralised energy world, it is becoming increasingly important to manage local electricity supply and demand efficiently. The technology developed by node.energy is the first integrated software-based solution to address this need. We were particularly impressed by the excellent market knowledge and implementation strength of the founders and are pleased to support the team in tapping this fast-growing market.”

In addition to High-Tech Gründerfonds as lead investor, five experienced investors from the FrankfurtRhineMain Business Angels e.V. also participate in the financing round. The fact that node.energy was able to convince both, our business angels and the HTGF shows the quality of the start-ups in the Frankfurt area. In this case, a practice-oriented innovation and an experienced founding team build a perfect match. We are particularly pleased that this is a product for better and more efficient energy use, as we are devoting increased attention to this sector” comments Dr. Burkhard Bonsels, board member of Business Angels FrankfurtRheinMain e. V., who is also participating in the financing round personally.

Facts, background information, dossiers
  • seed financing
  • start ups
  • node.energy
  • High-Tech Gründerfo…
More about High-Tech Gründerfonds Management
  • News

    neotiv secures seed funding from High-Tech Gründerfonds

    From basic research straight to a digital medical product: this vision has been turned into reality by neotiv. The team headed by Chief Executive Officer Dr. Chris Rehse and dementia researcher Prof. Emrah Düzel develops user-friendly apps that are able to measure the psychological effects ... more

    Focus on Medical Device Regulation

    The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterpri ... more

    BORN2GROW supports biotech start-up Venneos with its further growth

    Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q – a silicon chip-based imaging system for analysing biological cells. “We are thrilled to have BORN2GROW o ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE